Functional groups on polystyrene model nanoparticles: influence on protein adsorption.

The surface characteristics of intravenously administered particulate drug carriers decisively influence the protein adsorption that is regarded as a key factor for the in vivo fate of the carriers. Latex nanoparticles were synthesized to study the influence of different basic and acidic functional groups on particulate surfaces on the protein adsorption from human serum. The protein mass adsorbed to the particles was assessed by BCA protein assay, the protein adsorption patterns were analyzed by two-dimensional electrophoresis. Considerable differences in the protein adsorption with regard to preferential adsorbed proteins were detectable for the different functional groups. Possible correlations between the surface characteristics and the protein adsorption are shown and discussed. The knowledge concerning the interactions of proteins and nanoparticles can be used for a rational development of particulate drug carriers and can also be useful for an optimized design of medical devices, e.g., hemodialysis membranes or implants.

[1]  Interactions of functionalized polystyrene derivatives with the complement system in human serum. , 1991, Journal of biomaterials science. Polymer edition.

[2]  R. Schwendener,et al.  The effects of charge and size on the interaction of unilamellar liposomes with macrophages. , 1984, Biochimica et biophysica acta.

[3]  R. Müller,et al.  Fat emulsions based on structured lipids (1,3-specific triglycerides): an investigation of the in vitro interaction with plasma proteins. , 1996, Clinical nutrition.

[4]  R. Müller,et al.  The role of plasma proteins in brain targeting: species dependent protein adsorption patterns on brain-specific lipid drug conjugate (LDC) nanoparticles. , 2001, International journal of pharmaceutics.

[5]  R. Müller,et al.  Plasma protein adsorption patterns on emulsions for parenteral administration: Establishment of a protocol for two‐dimensional polyacrylamide electrophoresis , 1998, Electrophoresis.

[6]  M. Kazatchkine,et al.  Anticomplementary activity of dextran derivatives. , 1985, Biomaterials.

[7]  C. J. Oss,et al.  Phagocytosis as a Surface Phenomenon , 1978 .

[8]  R. Müller,et al.  Evaluation of desorption of proteins adsorbed to hydrophilic surfaces by two‐dimensional electrophoresis , 2001, Proteomics.

[9]  M. Kazatchkine,et al.  Regulation of the human alternative complement pathway: formation of a ternary complex between factor h, surface‐bound c3b and chemical groups on nonactivating surfaces , 1989, European journal of immunology.

[10]  S. Krilis,et al.  Identification of a region of beta 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[11]  H. Wurm.  beta 2-Glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles. , 1984, The International journal of biochemistry.

[12]  D. Hochstrasser,et al.  Kinetics of plasma protein adsorption on model particles for controlled drug delivery and drug targeting , 1996 .

[13]  M. Lück,et al.  Complement activation by model drug carriers for intravenous application: determination by two-dimensional electrophoresis. , 1999, Biomaterials.

[14]  R. Müller,et al.  Identification of plasma proteins facilitated by enrichment on particulate surfaces: Analysis by two‐dimensional electrophoresis and N‐terminal microsequencing , 1997, Electrophoresis.

[15]  D. Hochstrasser,et al.  Colloidal carriers for intravenous drug targeting: Plasma protein adsorption patterns on surface‐modified latex particles evaluated by two‐dimensional polyacrylamide gel electrophoresis , 1993, Electrophoresis.

[16]  R. Müller,et al.  Analysis of plasma protein adsorption onto polystyrene particles by two‐dimensional electrophoresis: Comparison of sample application and isoelectric focusing techniques , 2000, Electrophoresis.

[17]  H. Brewer,et al.  Activation of human post heparin lipoprotein lipase by apolipoprotein H (beta 2-glycoprotein I). , 1980, Biochemical and biophysical research communications.

[18]  H M Patel,et al.  Serum opsonins and liposomes: their interaction and opsonophagocytosis. , 1992, Critical reviews in therapeutic drug carrier systems.

[19]  R. Müller,et al.  Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[20]  M. Kazatchkine,et al.  The ability of Sephadex to activate human complement is suppressed in specifically substituted functional Sephadex derivatives. , 1988, Molecular immunology.

[21]  R. Müller,et al.  Nonviral gene delivery to the lung with copolymer-protected and transferrin-modified polyethylenimine. , 2002, Biochimica et biophysica acta.

[22]  K. Tauer,et al.  Emulsion polymerization in the presence of polymerizable emulsifiers and surface active initiators , 1990 .

[23]  B. Paulke,et al.  Electrophoretic 3D-Mobility Profiles of Latex Particles with Different Surface Groups , 1995 .

[24]  W. Norde,et al.  Why proteins prefer interfaces. , 1991, Journal of biomaterials science. Polymer edition.

[25]  P. Artursson,et al.  Biopharmaceutics of Microparticulate Drug Carriers , 1987, Annals of the New York Academy of Sciences.

[26]  H. Ayhan,et al.  Phagocytosis of monosize polystyrene-based microspheres having different size and surface properties. , 1995, Journal of biomaterials science. Polymer edition.

[27]  C. Haynes,et al.  Globular proteins at solid/liquid interfaces , 1994 .

[28]  R. Müller,et al.  Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption. , 2000, International journal of pharmaceutics.

[29]  A. L. Adams,et al.  Adsorption of proteins out of plasma and solutions in narrow spaces , 1986 .

[30]  M. Lück,et al.  Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics. , 1998, Journal of biomedical materials research.

[31]  M. Kazatchkine,et al.  Regulation by sulphonate groups of complement activation induced by hydroxymethyl groups on polystyrene surfaces. , 1993, Biomaterials.

[32]  M. Kamboh,et al.  Genetics of apolipoprotein H (β2-glycoprotein I) and anionic phospholipid binding , 1998, Lupus.